Indirect comparison of the immunogenicity of 15-valent and 20-valent pneumococcal conjugate vaccines in children using a 2+1 schedule
In a 2 + 1 schedule, PCV15 demonstrates immunogenicity comparable or superior to PCV20 across PCV13 serotypes, especially for serotype 3.
Authors
- Shahrul Mt‐Isa (ORCID: https://orcid.org/0000-0002-7163-8402)
- Justin Chumbley (ORCID: https://orcid.org/0009-0009-4271-2157)
- Jessica Weaver (ORCID: https://orcid.org/0000-0002-9861-3328)
- Natalie Banniettis
- Matthew S. Kelly (ORCID: https://orcid.org/0000-0001-8819-2315)
Institutions
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Decision Sciences (United States) (US)
- University of Arkansas for Medical Sciences (US)
Publication Details
- Journal
- Expert Review of Vaccines
- Published
- 2025-09-30
- DOI
- https://doi.org/10.1080/14760584.2025.2569037
- Citations
- 1
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 1.35